Precision Immunotherapy to Improve Sepsis OutcomesEvangelos J. Giamarellos‐Bourboulis, Maria Ntaganou, Peter Pickkers et al.|JAMA|2025Cited by 53
The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccineesJulie Van Coillie, Tamás Pongrácz, Johann Rahmöller et al.|EBioMedicine|2022Cited by 39
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Cinzia Bassoli, Tamás Pongrácz et al.|iScience|2023Cited by 25
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccinationBrent Appelman, Karlijn van der Straten, A. H. Ayesha Lavell et al.|EBioMedicine|2021Cited by 22
25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinationsA. H. Ayesha Lavell, W. Joost Wiersinga, A.E. Schramade et al.|Vaccine|2023Cited by 5